Aggregated China Business Blogs
Guosen Securities maintains Tiger Pharma’s buy rating: the main business continues to recover and non-recurring returns are relatively high
The “Fantasy Drifting” of a Container-Looking at China’s Economic Warmth from the “Sea, Land and Air Index”
China’s regulators announce real-name system for online commenting
Kaczyński’s Threat to Europe
Baidu Leads $15M Series C Round For Fashion Site Yoka
Australian writer Yang Hengjun detained in ChinaChina emissions rules threaten carmaker profitsCGN Capital Reaches $292M First Close On China Renewable Energy Fund
AMF Pensionsforsakring AB Has $3.36 Million Position in Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) Watch List News
China’s central bank fails to ease cash squeeze